Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic PIPAC for Reducing the Risk of Peritoneal Carcinomatosis in Patients With Colorectal Cancer: the PROPAC Randomized Clinical Trial

NCT06839092 is registered in ClinicalTrials.gov with Jeremy Meyer as lead sponsor.

NCT NCT06839092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06839092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic PIPAC for Reducing the Risk of Peritoneal Carcinomatosis in Patients With Colorectal Cancer: the PROPAC Randomized Clinical Trial
Lead sponsor
Jeremy Meyer
Phase
Phase 3
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
January 31, 2034
Enrollment
160 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, colorectal cancer control and prevention, colorectal cancer stage ii, colorectal cancer stage iii